Ocuphire Pharma, Inc. Quarterly Other Assets, Current in USD from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Ocuphire Pharma, Inc. quarterly Other Assets, Current history and growth rate from Q4 2011 to Q2 2024.
  • Ocuphire Pharma, Inc. Other Assets, Current for the quarter ending June 30, 2024 was $87K, a 93.3% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $87K +$42K +93.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $89K +$11K +14.1% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $102K +$22K +27.5% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $51K -$10K -16.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $45K +$14K +45.2% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $78K +$45K +136% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $80K +$9K +12.7% Dec 31, 2022 10-K 2024-03-08
Q3 2022 $61K +$15K +32.6% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $31K -$42K -57.5% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $33K +$7K +26.9% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $71K +$45K +173% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $46K Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $73K Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $26K Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $26K +$21K +420% Dec 31, 2020 10-K 2022-03-24
Q4 2019 $5K -$550K -99.1% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $606K -$27.9K -4.39% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $662K -$117K -15% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $410K -$81.5K -16.6% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $555K +$44.8K +8.78% Dec 31, 2018 10-K 2020-02-21
Q3 2018 $634K -$31.8K -4.78% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 $779K +$112K +16.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $492K +$67.5K +15.9% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $511K +$81.6K +19% Dec 31, 2017 10-K 2019-03-07
Q3 2017 $666K -$9.29K -1.38% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $667K -$129K -16.2% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $424K -$205K -32.6% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $429K -$292K -40.5% Dec 31, 2016 10-K 2018-03-09
Q3 2016 $675K -$125K -15.6% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $796K -$30.5K -3.69% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $629K +$87K +16% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $721K +$359K +99.5% Dec 31, 2015 10-K 2017-02-24
Q3 2015 $801K +$269K +50.5% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $827K +$177K +27.2% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $542K -$96.4K -15.1% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $361K -$108K -23.1% Dec 31, 2014 10-K 2016-03-14
Q3 2014 $532K +$44.2K +9.06% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $650K +$271K +71.7% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 $639K +$469K +275% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $469K +$293K +167% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $488K +$295K +153% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $379K +$104K +37.8% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 $170K Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $176K +$6.14K +3.61% Dec 31, 2012 10-K 2014-03-21
Q3 2012 $192K Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $275K Jun 30, 2012 10-Q 2012-08-08
Q4 2011 $170K Dec 31, 2011 10-K 2013-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.